Literature DB >> 24252053

Evaluation of submandibular versus labial salivary gland fibrosis in IgG4-related disease.

Kenichi Takano1, Yoshiko Keira, Nobuhiko Seki, Ayumi Abe, Motohisa Yamamoto, Hiroki Takahashi, Tetsuo Himi.   

Abstract

The newly comprehensive diagnostic criteria in 2011 emphasize the importance of IgG4-positive plasmacyte infiltration along with storiform or swirling fibrosis and obliterative phlebitis in diagnosing IgG4-related disease(RD). Although labial salivary gland (LSG) biopsy is a minimally invasive and convenient procedure for obtaining tissues, LSG fibrosis is thought to be inconspicuous or absent in IgG4-RD cases. In this study we evaluated 15 patients with IgG4-RD, in whom both submandibular gland (SMG) and LSG biopsies were performed at the same time. Histological evaluation revealed fibrosis in all the SMG specimens but in only one LSG specimen (6.7%). The diagnosis of IgG4-RD is primarily based on its morphological appearance on biopsy. The results of this study demonstrated that although more invasive than LSG biopsy, SMG biopsy is recommended for accurate diagnosis of IgG4-related MD and to exclude malignant diseases.

Entities:  

Keywords:  IgG4-related disease; Mikuicz's disease; Salivary gland biopsy; Salivary gland fibrosis

Mesh:

Substances:

Year:  2013        PMID: 24252053     DOI: 10.3109/14397595.2013.853336

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  2 in total

Review 1.  Salivary Gland Pathology in IgG4-Related Disease: A Comprehensive Review.

Authors:  Ilaria Puxeddu; Riccardo Capecchi; Filippo Carta; Antonio Gaetano Tavoni; Paola Migliorini; Roberto Puxeddu
Journal:  J Immunol Res       Date:  2018-04-01       Impact factor: 4.818

2.  Needle biopsy compared with surgical biopsy: pitfalls of small biopsy in histologial diagnosis of IgG4-related disease.

Authors:  Yanying Liu; Fei Yang; Xiying Chi; Yuxin Zhang; Jiangnan Fu; Wenjie Bian; Danhua Shen; Zhanguo Li
Journal:  Arthritis Res Ther       Date:  2021-02-10       Impact factor: 5.156

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.